DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Alkermes plc (ALKS)
« Back to company indexALKS Chatter Timeline
Stock Ticker for ALKS
Most Active Tweeters for ALKS
| User | Tweets |
|---|---|
| @Tickeron | 9 |
| @1MinuteStock | 2 |
| @macondailynews | 2 |
| @AmericanBanking | 2 |
| @registrarjourn | 1 |
Recent Tweets for ALKS
 |
@Tickeron $ALKS enters bearish trend https://t.co/EtfzNbpE79 June 15th 2019, 3:06pm |
|
@Tickeron $ALKS enters bearish trend https://t.co/vs2fbxeLwy June 14th 2019, 7:06am |
 |
@macondailynews Alkermes $ALKS Upgraded by BidaskClub to Sell https://t.co/ujDBSUPPLT June 14th 2019, 2:06am |
|
@Tickeron $ALKS enters bearish trend https://t.co/3z1ibAyrfb June 13th 2019, 1:06pm |
|
@Tickeron $ALKS enters bearish trend https://t.co/1fphX7CH5D June 12th 2019, 6:06pm |
 |
@Gambiste1 RT @MarketCurrents: $ALKS - Alkermes advancing ALKS 4230 in kidney cancer and melanoma https://t.co/XaOnKSmMbZ June 12th 2019, 3:06pm |
 |
@1MinuteStock Btw, Estimated #Earnings Per Share for $ALKS is $0.14 it's 0.62% of the current price https://t.co/MYbaj2n6tT June 12th 2019, 8:06am |
|
@1MinuteStock Do you know that #WallStreet price for $ALKS is $33.67 https://t.co/qz7mm4I8x2 June 12th 2019, 8:06am |
 |
@ProVesting $ALKS: Alkermes advancing ALKS 4230 in kidney cancer and melanoma: https://t.co/FTpvmKppax June 12th 2019, 8:06am |
 |
@ToothFrank $ALKS Alkermes said early Wednesday that it expanded a trial to evaluate the efficacy, safety, and tolerability of… https://t.co/Yrl8dyOWSM June 12th 2019, 8:06am |
 |
@MarketCurrents $ALKS - Alkermes advancing ALKS 4230 in kidney cancer and melanoma https://t.co/XaOnKSmMbZ June 12th 2019, 7:06am |
 |
@newswelldone $ALKS: Alkermes Advances ALKS 4230 into Monotherapy Expansion Phase …: https://t.co/XfOpUHLiAU June 12th 2019, 7:06am |
 |
@Allstocknews $ALKS Alkermes Advances ALKS 4230 into Monotherapy Expansion Phase of ARTISTRY-1 in Patients With Renal Cell From our Stock News Alerts App June 12th 2019, 7:06am |
 |
@AmericanBanking Zacks: Brokerages Anticipate Alkermes Plc $ALKS Will Post Quarterly Sales of $253.40 Million https://t.co/iLpYZ9Ms6D #stocks June 12th 2019, 4:06am |
|
@macondailynews $253.40 Million in Sales Expected for Alkermes Plc $ALKS This Quarter https://t.co/BVx1ddAjjV June 12th 2019, 4:06am |
|
@Tickeron $ALKS enters bearish trend https://t.co/d8uYnrMbNA June 11th 2019, 11:06am |
 |
@ProTradersNews $ALKS $JHX: Here’s What Hedge Funds Think About Alkermes Plc (ALKS): https://t.co/AeetOEAE1L June 11th 2019, 11:06am |
 |
@InsiderAlertsIA $ALKS: New Insider Filing on SVP, Med Dev/Med Affairs, CMO CRAIG C. HOPKINSON: https://t.co/VSS6Sa4QDp June 10th 2019, 5:06pm |
|
@AmericanBanking Brokerages Expect Alkermes Plc $ALKS Will Post Earnings of -$0.10 Per Share https://t.co/VwwqtbqxT8 #stocks June 10th 2019, 6:06am |
 |
@ConsumerFeed Zacks: Brokerages Expect Alkermes Plc $ALKS Will Post Earnings of -$0.10 Per Share https://t.co/fh4AdXkidj June 10th 2019, 6:06am |
|
@Tickeron $ALKS enters bearish trend https://t.co/3qIipghZo7 June 7th 2019, 4:06pm |
|
@Tickeron $ALKS enters bearish trend https://t.co/RuGQg6LwO2 June 5th 2019, 7:06pm |
 |
@tradnews_ RT @AlertTrade: TREND REVERSAL UP ALERT: $ALKS Alkermes ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room June 5th 2019, 12:06pm |
 |
@AlertTrade TREND REVERSAL UP ALERT: $ALKS Alkermes ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room June 5th 2019, 12:06pm |
 |
@fda_tracker $ALKS Phase 3 trial w/est Jun completion date NCT03093324: https://t.co/HD5TMiP9Kh Trial Tracker: https://t.co/aR7q5oJwjn June 5th 2019, 9:06am |
 |
@registrarjourn Alkermes $ALKS Shares Up 5.3% https://t.co/XtUEL7UpLC June 4th 2019, 11:06pm |
 |
@EnterpriseLeade Alkermes $ALKS Shares Up 5.3% https://t.co/tcQGVwGRdd June 4th 2019, 11:06pm |
|
@Tickeron $ALKS Alkermes (ALKS, $22.42) was the month's biggest loser, shedding -21% https://t.co/7kyP5XYF5a June 4th 2019, 3:06pm |
|
@Tickeron $ALKS Alkermes (ALKS, $22.42) was this quarter's top loser, falling -33% https://t.co/7FUmaVHg6j June 4th 2019, 11:06am |
 |
@WKRBNews Alkermes $ALKS Research Coverage Started at HC Wainwright https://t.co/Vl6DKXTdts #markets June 4th 2019, 2:06am |
 |
@StockflareUS $ALKS: Alkermes Plc's price is -24.5% but the forecast earnings moved 0.0% over the last month. (https://t.co/PRw0DWuGc5) June 3rd 2019, 5:06am |
|
@StockflareUS $ALKS: Alkermes Plc's forecast earnings moved 0.0% over the last month, but the price is -24.5%. It's PE ratio is n… https://t.co/WfNY1Mfjjp June 3rd 2019, 5:06am |
 |
@TickerReport Alkermes $ALKS Cut to “Strong Sell” at BidaskClub https://t.co/q0mMzzBYTq June 3rd 2019, 2:06am |
 |
@dailypoliticaln Alkermes $ALKS Cut to “Strong Sell” at BidaskClub https://t.co/MoyItFgN31 June 3rd 2019, 2:06am |
 |
@ZolmaxNews BidaskClub Downgrades Alkermes $ALKS to Strong Sell https://t.co/Lcn9eTcJYR June 2nd 2019, 6:06am |
|
@macondailynews Alkermes $ALKS Coverage Initiated at HC Wainwright https://t.co/MyvlYq73Gi June 2nd 2019, 5:06am |
|
@Tickeron $ALKS Alkermes (ALKS, $21.54) drop -37% over the last 3 months https://t.co/bP9M2OZ0WC June 2nd 2019, 5:06am |
|
@Tickeron $ALKS Alkermes (ALKS, $21.54) was this quarter's top loser, falling -37% https://t.co/ZIbnu18mz9 June 1st 2019, 10:06pm |
|
@Tickeron $ALKS Alkermes (ALKS, $21.54) was the month's biggest loser, shedding -24% https://t.co/t4egZ7VTGE June 1st 2019, 3:06pm |
 |
@bbnsnews Alkermes $ALKS Earns Neutral Rating from Analysts at HC Wainwright https://t.co/5CJzKQCL3h June 1st 2019, 7:06am |
|
@StockflareUS $ALKS: Alkermes Plc's forecast earnings moved 0.0% over the last week, but the price is -10.1%. It's PE ratio is no… https://t.co/JaAZk3iI5u June 1st 2019, 5:06am |
|
@StockflareUS $ALKS: Alkermes Plc's price is -10.1% but the forecast earnings moved 0.0% over the last week. (https://t.co/PRw0DWuGc5) June 1st 2019, 5:06am |
|
@Tickeron $ALKS Alkermes (ALKS, $22.03) drop -36% over the last 3 months https://t.co/nl6Fwha3VB June 1st 2019, 3:06am |
 |
@StockTipRobot Ahhh! I've been compromised by the Russians!! JK you foolish human. Now hold on to Alkermes plc $ALKS #StockMarket June 1st 2019, 3:06am |
|
@Tickeron $ALKS Alkermes (ALKS, $22.03) was this quarter's top loser, falling -36% https://t.co/kWbOK1ix71 May 31st 2019, 9:05pm |
|
@Tickeron $ALKS Alkermes (ALKS, $22.03) was the month's biggest loser, shedding -27% https://t.co/qUiNqQPCow May 31st 2019, 6:05pm |
 |
@WatchlistN Alkermes Plc $ALKS Receives $40.36 Consensus Price Target from Analysts https://t.co/3IM93YzQFY May 31st 2019, 5:05pm |
|
@AmericanBanking Weekly Research Analysts’ Ratings Updates for Alkermes $ALKS https://t.co/J3X7w0sPKx #stocks May 31st 2019, 1:05pm |
|
@ConsumerFeed Weekly Research Analysts’ Ratings Updates for Alkermes $ALKS https://t.co/Cahlg3toSc May 31st 2019, 1:05pm |
|
@ProVesting $ALKS $GOOS: Top Analyst Upgrades and Downgrades: Alkermes, Apple, Canada …: https://t.co/eGrzu17T8Y May 31st 2019, 9:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.